InspireMD (STU:II2) Shiller PE Ratio: (As of Sep. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:II2 InspireMD Inc STU:II2
47 GF Score
Price €0.73
GF Value €1.39
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is InspireMD Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


InspireMD  (STU:II2) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


InspireMD Shiller PE Ratio Related Terms


InspireMD Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for InspireMD's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InspireMD Shiller PE Ratio Chart

InspireMD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

InspireMD Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:II2 vs SNWV, PAVM, ELUT: Shiller PE Ratio Comparison

For the Medical Devices subindustry, InspireMD's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InspireMD Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where InspireMD's Shiller PE Ratio falls into.


STU:II2
47GF Score
InspireMD Inc STU:II2
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InspireMD Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

InspireMD's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, InspireMD's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.148/333.9520*333.9520
=-0.148

Current CPI (Jun. 2026) = 333.9520.

InspireMD Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -34,853.824 241.428 -48,211.078
201612 -38,394.000 241.432 -53,107.099
201703 -11,478.923 243.801 -15,723.518
201706 -7,188.944 244.955 -9,800.830
201709 -6,162.514 246.819 -8,338.029
201712 -2,331.226 246.524 -3,157.979
201803 -656.907 249.554 -879.070
201806 -98.354 251.989 -130.345
201809 -31.752 252.439 -42.005
201812 -32.962 251.233 -43.815
201903 -50.710 254.202 -66.619
201906 -21.107 256.143 -27.519
201909 -17.161 256.759 -22.320
201912 -7.695 256.974 -10.000
202003 -5.813 258.115 -7.521
202006 -2.602 257.797 -3.371
202009 -0.815 260.280 -1.046
202012 -1.233 260.474 -1.581
202103 -0.445 264.877 -0.561
202106 -0.382 271.696 -0.470
202109 -0.451 274.310 -0.549
202112 -0.469 278.802 -0.562
202203 -0.518 287.504 -0.602
202206 -0.558 296.311 -0.629
202209 -0.586 296.808 -0.659
202212 -0.566 296.797 -0.637
202303 -0.495 301.836 -0.548
202306 -0.222 305.109 -0.243
202309 -0.141 307.789 -0.153
202312 -0.119 306.746 -0.130
202403 -0.193 312.332 -0.206
202406 -0.204 314.175 -0.217
202409 -0.144 315.301 -0.153
202412 -0.181 315.605 -0.192
202503 -0.203 319.799 -0.212
202506 -0.225 322.561 -0.233
202509 -0.145 324.800 -0.149
202512 -0.120 324.054 -0.124
202603 -0.138 330.213 -0.140
202606 -0.148 333.952 -0.148

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is InspireMD (STU:II2) Overvalued in 2026?

Based on GuruFocus' analysis, InspireMD stock appears to be undervalued. The current stock price of €0.73 is trading 47.8% below its estimated GF Value™ of €1.39. GuruFocus considers InspireMD to be Possible Value Trap.

Key valuation signals for STU:II2:

  • Shiller PE Ratio:
  • GF Value™: €1.39 vs. price of €0.73 (47.8% below fair value)
  • GF Score™: 47/100 with 3 warning signs

No single metric tells the full story. See the STU:II2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


InspireMD Business Description

Other Exchanges NSPR:USA
Address 6303 Waterford District Drive, Suite 215, Miami, FL, USA, 33126
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
47GF Score

Get the complete analysis for STU:II2

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.73
Price
€1.39
GF Value